<?xml version="1.0" encoding="UTF-8"?>
<ref id="R8">
 <label>8.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Peterson</surname>
    <given-names>DE</given-names>
   </name>, 
   <name name-style="western">
    <surname>Barker</surname>
    <given-names>NP</given-names>
   </name>, 
   <name name-style="western">
    <surname>Akhmadullina</surname>
    <given-names>LI</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy</article-title>. 
  <source>J Clin Oncol</source>
  <year>2009</year>;
  <volume>27</volume>:
  <fpage>4333</fpage>â€“
  <lpage>8</lpage>. 
  <pub-id pub-id-type="doi">10.1200/JCO.2008.21.2381</pub-id>
  <pub-id pub-id-type="pmid">19636011</pub-id>
 </mixed-citation>
</ref>
